Case Study
Driving Genetic Testing and Patient Identification in an Ultra-Rare Disease
A pharma manufacturer with a first-to-market targeted treatment for APDS — an ultra-rare primary immunodeficiency — needed to find HCPs who may have undiagnosed APDS patients in their care. With a tiny eligible population and fragmented specialist landscape, the challenge was identifying and educating the right physicians before and after launch.
What’s Inside
- Reaching immunologists, hematologists, and allergists across a fragmented specialist network
- Multi-format content deployment to drive awareness and genetic testing intent
- Physician-level engagement data tracked across every content touchpoint
- Measurable increase in genetic testing referrals among engaged HCPs
